Ads
related to: signs of colorectal cancer- Treatment Tracker
Keep Track of Dosing
Keep Track Of Well-being
- Download Brochure
Learn More Here
Get The Brochure Here
- Patient Resources
Treatment Information
Metastatic CRC
- Metastatic CRC Treatment
View Dosing Information
and Side Effects
- mCRC Treatment Option
FDA Approved Treatment
HER2+ Treatment Option
- Important Safety Info
View Safety Information
& Available Resources
- Treatment Tracker
Search results
Critical signs and symptoms of colon cancer
Rolling Out· 12 hours agoThis article aims to provide a comprehensive overview of the critical signs and symptoms of colon cancer,
Panel recommends blood test to detect colon cancer for FDA approval
United Press International via Yahoo News· 3 hours agoA panel of U.S. Food and Drug Administration advisers on Thursday recommended approval for a new...
Blood test to detect colon cancer could move a step closer to FDA approval in the US
CNN via Yahoo News· 6 hours agoGuardant Health’s Shield tests could be the first approved blood screening test for colorectal ...
U.S. FDA advisers back approval for Guardant's blood-based cancer test
Reuters· 7 hours ago, opens new tab blood test to detect a cancer that begins in the colon or rectum. The panel voted...
To Your Good Health: The risk of colorectal cancer among young people is rising
The Mining Journal· 2 days agoROACH: I read in the paper that the rate of colorectal cancer has been rapidly rising since the...
Compugen stock target cut on colorectal cancer trial woes By Investing.com
Investing.com· 3 days agoThe revision follows the announcement that Compugen's combination therapy involving COM701 and...
Personal View: What I wish Ohioans knew about screening for colon cancer
Crain's Cleveland Business· 3 days agoIncreased dialogue around this spike in colorectal cancer is welcomed and much-needed, given that recent surveys show about 30% of Ohioans haven’t received ...
US FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
Reuters· 3 days ago, opens new tab experimental blood test for a cancer of colon or rectum may fail to detect some...
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term...
Digital Journal· 7 hours agoPoster highlights durable disease stabilization lasting beyond treatment completionResults suggest a unique, multimodal mechanism of action that differs from other cancer ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 7 hours ago- Once every 3-week dosing of SNS-101 demonstrates initial signs of promising clinical activity - - Pharmacokinetic and safety profile validate conditionally active approach - - Investor webcast to be held on Monday, June 3 at 8:00
